199
Views
15
CrossRef citations to date
0
Altmetric
Hepatobiliary

Prognostic significance of tumor-associated trypsin inhibitor (TATI) and human chorionic gonadotropin-β (hCGβ) in patients with hepatocellular carcinoma

, , , , &
Pages 1066-1073 | Received 08 Feb 2013, Accepted 13 May 2013, Published online: 29 Jul 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Kaijun Huang, Wenxuan Xie, Shutong Wang, Qiao Li, Xiangling Wei, Bin Chen, Yunpeng Hua, Shaoqiang Li, Baogang Peng & Shunli Shen. (2021) High SPINK1 Expression Predicts Poor Prognosis and Promotes Cell Proliferation and Metastasis of Hepatocellular Carcinoma. Journal of Investigative Surgery 34:9, pages 1011-1020.
Read now
Weimin Wu, Hao Gao, Xiaofeng Li, Shumin Peng, Jing Yu, Na Liu, Guangxi Zhan, Yong Zhu, Kai Wang & Xiaoqing Guo. (2019) β-hCG promotes epithelial ovarian cancer metastasis through ERK/MMP2 signaling pathway. Cell Cycle 18:1, pages 46-59.
Read now
Ulf-Håkan Stenman. (2016) Biomarker development, from bench to bedside. Critical Reviews in Clinical Laboratory Sciences 53:2, pages 69-86.
Read now
Shailendra Kapoor. (2014) Diagnostic and prognostic value of tumor-associated trypsin inhibitor in gastrointestinal malignancies. Scandinavian Journal of Gastroenterology 49:4, pages 514-515.
Read now

Articles from other publishers (11)

Dingyi Li, Xinxin Zhang, Zhiqiang Ding, Rongshuang Ai, Luyao Shi, Zimeng Wang, Qian He, Yilin Dong, Yiting Zhu, Wenzhong Ouyang & Yujuan He. (2022) Identification and Exploration of Serine Peptidase Inhibitor Kazal Type I (SPINK1) as a Potential Biomarker Correlated with the Progression of Non-Small Cell Lung Cancer. Cell Biochemistry and Biophysics 80:4, pages 807-818.
Crossref
Anni Sjöblom, Timo Carpén, Ulf-Håkan Stenman, Lauri Jouhi, Caj Haglund, Stina Syrjänen, Petri Mattila, Antti Mäkitie & Jaana Hagström. (2022) The Role of Human Chorionic Gonadotropin Beta (hCGβ) in HPV-Positive and HPV-Negative Oropharyngeal Squamous Cell Carcinoma. Cancers 14:12, pages 2830.
Crossref
Anni Sjöblom, Ulf-Håkan Stenman, Jaana Hagström, Lauri Jouhi, Caj Haglund, Stina Syrjänen, Petri Mattila, Antti Mäkitie & Timo Carpén. (2021) Tumor-Associated Trypsin Inhibitor (TATI) as a Biomarker of Poor Prognosis in Oropharyngeal Squamous Cell Carcinoma Irrespective of HPV Status. Cancers 13:11, pages 2811.
Crossref
Chengliang Zhu, Huan Han, Jie Li, Limin Xu, Fang Liu, Kailang Wu & Xinghui Liu. (2019) Hepatitis B Virus X Protein-Induced Serine Protease Inhibitor Kazal Type 1 Is Associated with the Progression of HBV-Related Diseases. BioMed Research International 2019, pages 1-7.
Crossref
Yuxin Yang, Yonghong Shi, Yanjuan Hou, Ying Lu & Jinliang Yang. (2018) CGB5 expression is independently associated with poor overall survival and recurrence-free survival in patients with advanced gastric cancer . Cancer Medicine 7:3, pages 716-725.
Crossref
Felix H. Shek, Ruibang Luo, Brian Y. H. Lam, Wing Kin Sung, Tak-Wah Lam, John M. Luk, Ming Sum Leung, Kin Tak Chan, Hector K. Wang, Chung Man Chan, Ronnie T. Poon & Nikki P. Lee. (2017) Serine peptidase inhibitor Kazal type 1 (SPINK1) as novel downstream effector of the cadherin-17/β-catenin axis in hepatocellular carcinoma. Cellular Oncology 40:5, pages 443-456.
Crossref
Kati Räsänen, Outi Itkonen, Hannu Koistinen & Ulf-Håkan Stenman. (2016) Emerging Roles of SPINK1 in Cancer. Clinical Chemistry 62:3, pages 449-457.
Crossref
Andrea Bellodi, Giulia Rivoli, Eleonora Arboscello, Giuseppe Fornarini, Giulio Fraternali Orcioni, Daniele Avenoso, Maurizio Miglino & Riccardo Ghio. (2015) Hepatosplenic T-cell Lymphoma with Aberrant Expression of Serum β-HCG: A Case Report. Tumori Journal 101:6, pages e160-e162.
Crossref
Aleksandra Głodek & Anna Jankowska. (2014) CGB activates ERK and AKT kinases in cancer cells via LHCGR-independent mechanism. Tumor Biology 35:6, pages 5467-5479.
Crossref
Outi Itkonen & Ulf-Håkan Stenman. (2014) TATI as a biomarker. Clinica Chimica Acta 431, pages 260-269.
Crossref
Holger G. Hass, Jürgen Jobst, Ulrich Vogel, Michael Scheurlen & Oliver Nehls. (2014) Overexpression of Tumor-Associated Trypsin Inhibitor (SPINK1/TATI) in Hepatitis C-Associated Hepatocellular Carcinoma: Potential Implications for Viral Hepatocarcinogenesis. Oncology Research and Treatment 37:12, pages 732-738.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.